Otto G - Search Results

1

GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro.

Xu J, Lucas R, Schuchmann M, Kühnle S, Meergans T, Barreiros AP, Lohse AW, Otto G, Wendel A. Xu J, et al. Among authors: otto g. J Immunol. 2003 Jul 15;171(2):938-47. doi: 10.4049/jimmunol.171.2.938. J Immunol. 2003. PMID: 12847265

2

CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation.

Moench C, Uhrig A, Lohse AW, Otto G. Moench C, et al. Among authors: otto g. Liver Transpl. 2004 Mar;10(3):434-9. doi: 10.1002/lt.20095. Liver Transpl. 2004. PMID: 15004773 Free article.

3

Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions.

Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, Barreiros AP, Lüth S, Schimanski CC, Schuchmann M, Schwarting A, Neurath M, Otto G, Galle PR, Lohse AW. Kuball J, et al. Among authors: otto g. Transplantation. 2004 Dec 27;78(12):1774-9. doi: 10.1097/01.tp.0000144183.77279.ec. Transplantation. 2004. PMID: 15614150

4

Hepatitis C virus re-infection: new perspectives.

Sprinzl MF, Otto G, Galle PR, Schuchmann M. Sprinzl MF, et al. Among authors: otto g. Clin Transplant. 2006;20 Suppl 17:117-23. doi: 10.1111/j.1399-0012.2006.00610.x. Clin Transplant. 2006. PMID: 17100711 Review.

5

Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).

Zimmermann T, Hoppe-Lotichius M, Tripkovic V, Barreiros AP, Wehler TC, Zimmermann A, Schattenberg JM, Heise M, Biesterfeld S, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: otto g. Eur J Intern Med. 2010 Jun;21(3):208-15. doi: 10.1016/j.ejim.2010.02.009. Epub 2010 Mar 24. Eur J Intern Med. 2010. PMID: 20493424

6

Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial.

Moench C, Barreiros AP, Schuchmann M, Bittinger F, Thiesen J, Hommel G, Kraemer I, Otto G. Moench C, et al. Among authors: otto g. Am J Transplant. 2007 Jun;7(6):1616-23. doi: 10.1111/j.1600-6143.2007.01804.x. Am J Transplant. 2007. PMID: 17511685 Free article. Clinical Trial.

7

Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.

Kanzler S, Lohse AW, Schirmacher P, Hermann E, Otto G, Meyer zum Büschenfelde KH. Kanzler S, et al. Among authors: otto g. Z Gastroenterol. 1996 Feb;34(2):128-31. Z Gastroenterol. 1996. PMID: 8659188

8

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.

Sprinzl MF, Reisinger F, Puschnik A, Ringelhan M, Ackermann K, Hartmann D, Schiemann M, Weinmann A, Galle PR, Schuchmann M, Friess H, Otto G, Heikenwalder M, Protzer U. Sprinzl MF, et al. Among authors: otto g. Hepatology. 2013 Jun;57(6):2358-68. doi: 10.1002/hep.26328. Hepatology. 2013. PMID: 23424039

9

The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation.

Moench C, Uhrig A, Lohse AW, Otto G. Moench C, et al. Among authors: otto g. Transplant Proc. 2003 Jun;35(4):1452-5. doi: 10.1016/s0041-1345(03)00372-5. Transplant Proc. 2003. PMID: 12826189

10

Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion.

Moench C, Moench K, Lohse AW, Thies J, Otto G. Moench C, et al. Among authors: otto g. Liver Transpl. 2003 Mar;9(3):285-9. doi: 10.1053/jlts.2003.50015. Liver Transpl. 2003. PMID: 12619026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters